P0 protein is a target antigen in chronic inflammatory demyelinating polyradiculoneuropathy

Annals of Neurology

Volumn 50, Issue 3, 2001, Pages 286-292

  Yan, Wei Xing ^a   Archelos, Juan J ^b   Hartung, Hans Peter ^b   Pollard, John D ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN G ANTIBODY; MYELIN PROTEIN;

AMINO ACID SEQUENCE; ANTIGEN BINDING; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMYELINATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOFLUORESCENCE; POLYRADICULONEUROPATHY; PRIORITY JOURNAL; PROTEIN PURIFICATION; WESTERN BLOTTING;

ANIMALS; AUTOANTIGENS; HUMANS; IMMUNOGLOBULIN G; MYELIN P0 PROTEIN; MYELIN SHEATH; NERVE FIBERS, MYELINATED; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING; RATS;

EID: 0034854410     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.1129     Document Type: Article

References (28)

1. Guillain-Barré syndrome
2. Chronic inflammatory demyelinating polyradiculoneuropathy
3. Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barré syndrome and Miller Fisher syndrome
4. Acute motor axonal neuropathy: An antibody-mediated attack on axolemma
5. Subclass of IgG antibody to GM1 epitope-bearing lipopolysaccharide of Campylobacter jejuni in patients with Guillain-Barré syndrome
6. Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome
7. Miller Fisher anti-GQlb antibodies: α-latrotoxin-like effects on motor end plates
8. Chronic inflammatory polyneuritis and neuropathies
9. Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy. A double-blind, sham-controlled, cross-over study
10. Immunoglobulin and complement deposits in peripheral nerves of patients with chronic relapsing polyneuropathy
11. Immune C3d on the surface of myelin sheaths in neuropathy
12. Passive transfer of demyelination by serum or IgG from chronic inflammatory demyelinating polyneuropathy patients
13. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP)
14. Failure of anti-GM1 IgG or IgM to induce conduction block following intraneural transfer
15. Chronic ophthalmoplegia and the anti-GQ1b antibody
16. Myelination in rat brain: Method of myelin isolation
17. SDS-polyacrylamide gel electrophoresis
18. Protein blotting
19. 2 fragments
20. Isolation and sequence determination of cDNA encoding the major structural protein of human peripheral myelin
21. Mouse P0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons
22. Endoneurial injection of antisera to myelin antigens
23. Protein zero (P0)-deficient mice show myelin degeneration in peripheral nerves characteristic of inherited human neuropathies
24. P0 myelin produces experimental allergic neuritis in Lewis rats
25. Cell adhesion molecules of immunoglobulin supergene family as tissue-specific autoantigens: Induction of experimental allergic neuritis (EAN) by P0 protein-specific T cell lines
26. Heterozygous P0 knockout mice develop a peripheral neuropathy that resembles chronic inflammatory demyelinating polyneuropathy (CIDP)
27. Antibody responses to P0 and P2 myelin proteins in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy
28. Anti-PMP22 antibodies in patients with inflammatory neuropathy